Citations

Clear

7552 citation(s) found for "Ku, Matthew".

Controversies in orthopaedic oncology
Thorkildsen, Joachim , Kurisunkal, Vineet , Puri, Ajay , Houdek, Matthew T. , Boyle, Richard A. , Ebeid, Walid , Botello, Eduardo , Laitinen, Minna , Funovics, Philipp T. , Jeys, Lee M , Thorkildsen, Joachim , Kurisunkal, Vineet , Puri, Ajay , Ruggieri, Pietro , Houdek, Matthew T , Ebeid, Walid , Botello, Eduardo , Morris, Guy V , Laitinen, Minna K , Jeys, Lee , Ruggieri, Pietro

Mayo Clinic

The Bone & Joint Journal | May 1, 2024 | Volume: 106-B | Issue: 5 | Pages: 425-429

10.1302/0301-620x.106b5.bjj-2023-1381 | PMID 38689572 Get It

Chondrosarcoma is the second most common surgically treated primary bone sarcoma. Despite a large number of scientific papers in the literature, there is still significant controversy about diagnostics, treatment of the primary tumour, subtypes, and complications. Therefore, consensus on its day-to-day treatment decisions is needed. In January 2024, the Birmingham Orthopaedic Oncology Meeting (BOOM) attempted to gain global consensus from 300 delegates from over 50 countries. The meeting focused on these critical areas and aimed to generate consensus statements based on evidence amalgamation and expert opinion from diverse geographical regions. In parallel, periprosthetic joint infection (PJI) in oncological reconstructions poses unique challenges due to factors such as adjuvant treatments, large exposures, and the complexity of surgery. The meeting debated two-stage revisions, antibiotic prophylaxis, managing acute PJI in patients undergoing chemotherapy, and defining the best strategies for wound management and allograft reconstruction. The objectives of the meeting extended beyond resolving immediate controversies. It sought to foster global collaboration among specialists attending the meeting, and to encourage future research projects to address unsolved dilemmas. By highlighting areas of disagreement and promoting collaborative research endeavours, this initiative aims to enhance treatment standards and potentially improve outcomes for patients globally. This paper sets out some of the controversies and questions that were debated in the meeting.Cite this article: Bone Joint J 2024;106-B(5):425–429.
Identification and Characterization of Immune Checkpoint Inhibitor–Induced Toxicities From Electronic Health Records Using Natural Language Processing
Barman, Hannah , Venkateswaran, Sriram, Santo, Antonio , Yoo, Unice, Silvert, Eli , Raghunathan, Bharathwaj, Kottschade, Lisa A. , Block, Matthew S. , Chandler, G. Scott , Zalis, Joshua, Wagner, Tyler E. , Mohindra, Rajat , Santo, Antonio Del , Kottschade, Lisa A , Block, Matthew S , Chandler, G Scott , Wagner, Tyler E , Mohindra, Rajat , Venkateswaran, Sriram, Rao, Krishna

Mayo Clinic

JCO Clinical Cancer Informatics | April 30, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/cci.23.00151 | PMID 38687915 Get It

PURPOSE Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, yet their use is associated with immune-related adverse events (irAEs). Estimating the prevalence and patient impact of these irAEs in the real-world data setting is critical for characterizing the benefit/risk profile of ICI therapies beyond the clinical trial population. Diagnosis codes, such as International Classification of Diseases codes, do not comprehensively illustrate a patient's care journey and offer no insight into drug-irAE causality. This study aims to capture the relationship between ICIs and irAEs more accurately by using augmented curation (AC), a natural language processing–based innovation, on unstructured data in electronic health records. METHODS In a cohort of 9,290 patients treated with ICIs at Mayo Clinic from 2005 to 2021, we compared the prevalence of irAEs using diagnosis codes and AC models, which classify drug-irAE pairs in clinical notes with implied textual causality. Four illustrative irAEs with high patient impact—myocarditis, encephalitis, pneumonitis, and severe cutaneous adverse reactions, abbreviated as MEPS—were analyzed using corticosteroid administration and ICI discontinuation as proxies of severity. RESULTS For MEPS, only 70% (n = 118) of patients found by AC were also identified by diagnosis codes. Using AC models, patients with MEPS received corticosteroids for their respective irAE 82% of the time and permanently discontinued the ICI because of the irAE 35.9% (n = 115) of the time. CONCLUSION Overall, AC models enabled more accurate identification and assessment of patient impact of ICI-induced irAEs not found using diagnosis codes, demonstrating a novel and more efficient strategy to assess real-world clinical outcomes in patients treated with ICIs.
Neoadjuvant Soft Tissue Ablation Utilizing Aliya™ Pulsed Electric Fields With Systemic Therapy in Early-stage Resectable Non-small Cell Lung Cancer (NSCLC)- VIGOR Study
Reisenauer, Janani , DiBardino, David M. , Criner, G.J., Callstrom, Matthew R. , Panero, J., Krimsky, William , Criner, G.J., Hunt, Stephen James , Panero, J.

Mayo Clinic

C110. SURFING THE INNOVATION WAVE IN SAN DIEGO: CUTTING-EDGE LUNG CANCER BIOMARKERS, DIAGNOSTICS AND TREATMENTS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A6883-A6883

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6883 Get It

SARS-CoV-2 Viremia Associates With Thrombosis and Mortality in the ACTIV-4a Trial
Zuchelkowski, Benjamin E. , Naqvi, Asma , Qin, S., Zhang, Li , Morris, Amy, Jacobs, Jordan, Nouraie, Mehdi , Zhang, Y., Dela Cruz, Charles S , McVerry, Bryan J , Morris, A., Neal, Matthew D , Seheult, Jansen N. , Kitsios, Georgios D , Mellors, John W , Kim, P., Bain, William G

Mayo Clinic

C18. TRANSLATING SCIENCE IN RESPIRATORY INFECTIONS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A5011-A5011

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5011 Get It

Association Between Adjunctive Vasopressors and Short-term Mortality in Adults With Septic Shock: A Systematic Review and Meta-analysis
Turpin, Brittany D. Bissell, Falck–Ytter, Yngve , Bauer, Seth R , Wieruszewski, Patrick M. , Dugar, Siddharth , Sacha, Gretchen , Sato, Ryota , Siuba, Matthew , Schleicher, Mary , Vachharajani, Vidula , Morgan, Rebecca L.

Mayo Clinic

C39. PNEUMONIA AND SEPSIS: EPIDEMIOLOGY, TREATMENTS, AND OUTCOMES | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A5482-A5482

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5482 Get It

Contemporary Aseptic Revision Total Hip Arthroplasty in Patients ≤50 Years of Age
Carender, Christopher N. , Bothun, Cole E. , Sierra, Rafael J. , Trousdale, Robert T. , Abdel, Matthew P. , Bedard, Nicholas A. , Abdel, Matthew P , Sierra, Rafael J , Bedard, Nicholas A

Mayo Clinic

Journal of Bone and Joint Surgery | April 30, 2024 | Volume: 106 | Issue: 12 | Pages: 1108-1116

10.2106/jbjs.23.01467 | PMID 38687829 Get It

Background: There has been a paucity of long-term outcomes data on aseptic revision total hip arthroplasties (THAs) in the young adult population. The purpose of this study was to evaluate implant survivorship, complications, and clinical outcomes in a large cohort of contemporary aseptic revision THAs in patients ≤50 years of age at the time of the surgical procedure. Methods: We identified 545 aseptic revision THAs performed at a single academic institution from 2000 to 2020 in patients who were 18 to 50 years of age. Patients who underwent conversion THAs and patients with a history of any ipsilateral hip infection were excluded. The mean age was 43 years, the mean body mass index (BMI) was 29 kg/m 2 , and 63% were female. The index indication for revision THA was aseptic loosening in 46% of cases, polyethylene wear or osteolysis in 28% of cases (all revisions of conventional polyethylene), and dislocation in 11% of cases. There were 126 hips (23%) that had undergone at least 1 previous revision (median, 1 revision [range, 1 to 5 revisions]). The mean follow-up was 10 years. Results: In the entire cohort, the 20-year survivorship free of any re-revision was 76% (95% confidence interval [95% CI], 69% to 82%). There were 87 re-revisions, with 31 dislocations, 18 cases of aseptic loosening of the femoral component, and 16 periprosthetic joint infections (PJIs) being the most common reasons for re-revision. Dislocation as the indication for the index revision was associated with an increased risk of re-revision (hazard ratio, 2.9; p < 0.001). The 20-year survivorship free of any reoperation was 73% (95% CI, 66% to 78%). There were 75 nonoperative complications (14%), including 32 dislocations. The mean Harris hip score significantly improved (p < 0.001) from 65 preoperatively to 81 at 10 years postoperatively. Conclusions: Contemporary aseptic revision THAs in patients ≤50 years of age demonstrated a re-revision risk of approximately 1 in 4 at 20 years. Dislocation, aseptic loosening of the femoral component, and PJI were the most common reasons for re-revision. Index revision THAs for dislocation had a 3 times higher risk of re-revision. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
How Are Professional Medical Societies Addressing Mass Incarceration and Carceral Health Through Official Society Policy Statements and Guidance?
Nguyen, N.V. , Sergew, Amen, DeMartino, Erin S. , Akgün, Kathleen M. , Griffith, Matthew F.

Mayo Clinic

C103. DISPARITIES AND SOCIAL DETERMINANTS OF HEALTH IN PULMONARY, CRITICAL CARE, AND SLEEP MEDICINE | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A6729-A6729

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6729 Get It

CAR T-cell Patients in the ICU: Not the Surge of Patients We Were Expecting
Gutiérrez, Cristina , Stephens, R. Scott , Feng, Lei , Rajendram, Prabalini , Dharshan, Ananda, McEvoy, Colleen , Hensley, Matthew K. , Nates, Joseph L. , Ibikunle, S., Mucha, Simon , Remor, N., Beasley, Matthew , Tharwani, Arsal , Initiative, CAR-ICU, Herr, Megan M. , May, H., Moraes, Alice Gallo de , Mead, E., Brown, Anne Rain , Westin, Jason R. , Remor, N., Beasley, M., Pastores, Stephen M.

Mayo Clinic

A41. REVIEWING ALL THE SYSTEMS: ADVANCES IN NON-PULMONARY CRITICAL CARE | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1544-A1544

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1544 Get It

Developing a Machine Learning Algorithm That Analyzes Voice Patterns to Identify Risk of Aspiration
Abdalla, Abdelmohaymin , Charney, Sara , Holyfield, Stacy , Brown, Alexandra R. , Higgins, Matthew , Ortega, Victor E. , Varghese, C., Zhang, J., Brown, A., Higgins, M., Liss, Julie , Zhang, Nan , Lott, David G. , Berisha, Visar

Mayo Clinic

A13. TOWARDS IMPLEMENTATION: NEW BIOMARKERS IN ILD | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1004-A1004

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1004 Get It